Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × OTHER_GOV × Dexamethasone × Clear all

Phase

Phase 2 4 Phase NA 1 Phase 3 1 Phase 2/3 1 Phase 1 1

Status

Sponsor Class

OTHER 108 INDUSTRY 99 NETWORK 40 NIH 28 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Conditions

Hypersensitivity 1

Interventions

Radiotherapy 8 Carboplatin 6 Capecitabine 6 Fluorouracil 5 Cisplatin 5 Paclitaxel 4 Gemcitabine 4 Docetaxel 4 Tamoxifen 3 Oxaliplatin 3 Neoadjuvant Therapy 3 Hydralazine 3 Etoposide 3 Drug Therapy 3 Cyclophosphamide 3 pegylated granulocyte colony-stimulating factor 2 palbociclib 2 Valproic Acid 2 Trastuzumab 2 Tranexamic Acid 2 Temozolomide 2 TP protocol 2 Surgical Procedures, Operative 2 Saline Solution 2 Radiotherapy, Adjuvant 2 Proton Pump Inhibitors 2 Pemetrexed 2 Nivolumab 2 Leucovorin 2 Irinotecan 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02349763 2020-10-23

DEPARO

Department of Medical Services Ministry of Public Health of Thailand

Phase 3 Completed

Hypersensitivity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡